In Vitro Test Articles & Analysis
40 news found
Preclinical development Creative Diagnostics provides in vitro biology, in vivo pharmacodynamics, PK/PD, toxicology and formulation development services that enable clients to make decisions about drug candidates, advance the development process and reduce future time and costs. The company's capabilities include HTS, in vitro microbiology, antimicrobial synergy ...
In diagnostics, the use of antigen rapid test kits and in vitro diagnostic hematology is accelerating early disease detection, improving treatment outcomes. ...
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. ...
In collaboration with renowned research institutions, CD Formulation has created an in vitro cytotoxicity testing platform specifically designed for microspheres and microneedles. ...
In addition to microsphere mass production, CD Formulation has expanded its expertise to include analytical testing, formulation development, stability testing, in vitro cytotoxicity testing, and ...
This critical step in the drug development process refers to the systematic evaluation of the safety of therapeutic drugs through laboratory studies and animals in vitro. Alfa Chemistry has established a drug safety evaluation system that meets international standards, helping clients to shorten the experimental time and reduce the cost as well. ...
CD Formulation provides detailed stability testing options for microspheres, including organic solvent resistance test, acid resistance test, alkaline resistance test, and accelerated experiment test. ...
It is significant to ensure that the detection is independent of viral concentrations and dependent only on the concentration and potency of tested sera. Therefore, it is important to accurately identify the infectious units of each virus with clear readings without exceeding the limited number of antibodies, which can be achieved by testing different viral ...
” At the meetings, the company presented data from IND-enabling studies demonstrating the safety and pharmacokinetic profile of OLX-07010 in in vitro and in vivo preclinical studies. In multiple animal species, OLX-07010, a novel small molecule inhibitor of tau self-association, demonstrated good oral bioavailability, with no significant adverse effects reported at the ...
Its PROTAC in vivo evaluation services encompass general studies of toxicology and in vivo pharmacokinetics, tests of allergy and in vitro hemolysis, as well as immunotoxicology analysis. ...
” Creative Diagnostics combines infection and analytical expertise to provide its global clients with the strongest portfolio of antiviral and antimicrobial in vitro testing services. Confronting the growing demands for new antiviral and antimicrobial compounds as treatments for infectious diseases, Creative Diagnostics spares no effort to ...
These results solve the critical issue of CTC rarity and pave the way for their use in early diagnostics of cancer, prognostics, theranostics, and in vitro personalized drug efficacy tests, including through CTC culture. ...
Since its founding in 2009, LightDeck has been dedicated to revolutionizing testing at the point of care- for faster, more accurate, less expensive, multi-plex testing of the most important diagnostic tests. ...
Theoretically, the 50% cytotoxic concentration (CC50) is the concentration of test compound required to reduce cell viability by 50%. Cytotoxicity of test compounds is best determined simultaneously with uninfected cells to obtain a 50% cytotoxic concentration (CC50) value. Cytotoxicity tests use proportionally increasing concentrations of the ...
In the US, the Merlin Test is already available as an internal Laboratory Developed Test in SkylineDx’ CAP/CLIA laboratory in San Diego (California, US). ...
About FoundationOne®Liquid CDx FoundationOne Liquid CDx is a qualitative next generation sequencing based in vitro diagnostic test for prescription use only that uses targeted high throughput hybridization-based capture technology to analyze 324 genes utilizing circulating cell-free DNA (cfDNA) isolated from plasma derived from anti-coagulated peripheral ...
The results show the synergistic effect of combining CYNK-101 with daratumumab to drive antibody dependent cellular cytotoxicity activity against CD38+ hematological malignancies in vitro and in vivo. In these studies, CYNK-101 was not susceptible to daratumumab-directed fratricide and did not display on-target, off-tumor cytotoxicity, suggesting CYNK-101 may be a unique NK cell ...
Earlier this month, the company announced that a full range of drug analysis services are now available for clients across the globe who are engaged with new drug development. The analytical testing of pharmaceutical products involves chemical, physical and sometimes microbiological analysis. “More specifically, this process involves aspects of identifying novel drugs, ...
In-network coverage of FoundationOne CDx and FoundationOne Liquid CDx testing will support broader access to precision cancer care and may lead to lower out-of-pocket costs for patients who receive any such testing in accordance with their TRICARE policy. ...
There is an intense need for more accurate screening methods during preclinical studies using in vitro assays that more closely mimic in vivo conditions. Currently, only 12% of drugs that begin phase 1 clinical trials move on to eventually receive FDA approval. ...